CRDL
Cardiol Therapeutics Inc - Ordinary Shares - Class A

5,556
Loading...
Loading...
News
all
press releases
Why Cardiol Therapeutics (CRDL) Stock Is Down 20% Today
Cardiol Therapeutics shares are trading lower by 20% Wednesday morning. The company announced a $13.5 million public offering. read more...
Benzinga·11mo ago
News Placeholder
More News
News Placeholder
Cardiol Therapeutics Gains Key Legal Consent
Cardiol Therapeutics (TSE:CRDL) has released an update. Cardiol Therapeutics Inc. has received consent from Borden Ladner Gervais LLP for the use o...
TipRanks Financial Blog·1y ago
News Placeholder
Analysts Offer Insights on Healthcare Companies: Cardiol Therapeutics (CRDL), Paragon 28 (FNA) and Intra-Cellular Therapies (ITCI)
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cardiol Therapeutics (CRDL Research Report), Paragon 28...
TipRanks Financial Blog·1y ago
News Placeholder
CRDL Stock Earnings: Cardiol Therapeutics Beats EPS for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips CRDL stock results show that Cardiol Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. The post...
InvestorPlace·1y ago
News Placeholder
Cardiol Therapeutics Progresses in Heart Disease Trials
Cardiol Therapeutics Inc. (TSE:CRDL) has released an update. Cardiol Therapeutics Inc. has made significant strides by completing patient enrollmen...
TipRanks Financial Blog·1y ago
News Placeholder
Cardiol Therapeutics Announces Year-End 2023 Update on Operations
Completed patient enrollment in the Phase II MAvERIC-Pilot study evaluating CardiolRx in patients withrecurrent pericarditis, with topline results expected in Q2 2024CardiolRx granted...
Newsfile Corp. - News Releases·1y ago
News Placeholder
Cardiol Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference Transcript
Related Stocks: TSX:CRDL...
GuruFocus·2y ago
News Placeholder
Cardiol Therapeutics Inc at Emerging Growth Conference Transcript
Related Stocks: TSX:CRDL...
GuruFocus·2y ago
News Placeholder
Cardiol Therapeutics Inc at Canaccord Genuity Growth Conference Transcript
Related Stocks: TSX:CRDL...
GuruFocus·2y ago
News Placeholder
Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis
Topline Results Expected in Q2 2024This is a Designated News Release.Toronto, Ontario--(Newsfile Corp. - February 21, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ('Cardiol' or the...
Newsfile Corp. - News Releases·2y ago

Latest CRDL News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.